Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells

References

• Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70:389-99; PMID:1643657; http://dx.doi.org/10.1016/0092-8674(92)90163-7
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992; 70:401-10; PMID:1643658; http://dx.doi.org/10.1016/0092-8674(92)90164-8
   PubMed Web of Science ®Google Scholar
• Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992; 267:2524-9; PMID:1733949
   PubMed Web of Science ®Google Scholar
• Nishimasu H, Okudaira S, Hama K, Mihara E, Dohmae N, Inoue A, Ishitani R, Takagi J, Aoki J, Nureki O. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat Struct Mol Biol 2011; 18:205-12; PMID:21240269; http://dx.doi.org/10.1038/nsmb.1998
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Mikami S, Sugino H, Yoshikawa A, Hashimoto A, Onodera Y, Furukawa S, Handa H, Oikawa T, Okada Y, et al. Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nat Commun 2016; 7:10656; PMID:26854204; http://dx.doi.org/10.1038/ncomms10656
   PubMed Web of Science ®Google Scholar
• Sabe H. Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J Biochem 2003; 134:485-9; PMID:14607973; http://dx.doi.org/10.1093/jb/mvg181
   PubMed Web of Science ®Google Scholar
• Ridley AJ. Rho GTPase signalling in cell migration. Curr Opin Cell Biol 2015; 36:103-12; PMID:26363959; http://dx.doi.org/10.1016/j.ceb.2015.08.005
   PubMed Web of Science ®Google Scholar
• Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004; 265:23-32; PMID:14697350; http://dx.doi.org/10.1016/j.ydbio.2003.06.003
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 2003; 302:1704-9; PMID:14657486; http://dx.doi.org/10.1126/science.1092053
   PubMed Web of Science ®Google Scholar
• Ridley AJ. Life at the leading edge. Cell 2011; 145:1012-22; PMID:21703446; http://dx.doi.org/10.1016/j.cell.2011.06.010
   PubMed Web of Science ®Google Scholar
• D'Souza-Schorey C, van Donselaar E, Hsu VW, Yang C, Stahl PD, Peters PJ. ARF6 targets recycling vesicles to the plasma membrane: insights from an ultrastructural investigation. J Cell Biol 1998; 140:603-16; PMID:9456320; http://dx.doi.org/10.1083/jcb.140.3.603
   PubMed Web of Science ®Google Scholar
• Radhakrishna H, Al-Awar O, Khachikian Z, Donaldson JG. ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. J Cell Sci 1999; 112(Pt 6):855-66; PMID:10036235
   PubMed Web of Science ®Google Scholar
• Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker E-B, Friedl P. Compensation mechanism in tumor cell migration: mesenchymal–amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160:267-77; PMID:12527751; http://dx.doi.org/10.1083/jcb.200209006
   PubMed Web of Science ®Google Scholar
• Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003; 5:711-9; PMID:12844144; http://dx.doi.org/10.1038/ncb1019
   PubMed Web of Science ®Google Scholar
• Carragher NO, Walker SM, Scott Carragher LA, Harris F, Sawyer TK, Brunton VG, Ozanne BW, Frame MC. Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 2006; 25:5726-40; PMID:16652152; http://dx.doi.org/10.1038/sj.onc.1209582
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15:178-96; PMID:24556840; http://dx.doi.org/10.1038/nrm3758
   PubMed Web of Science ®Google Scholar
• Sedgwick AE, Clancy JW, Olivia Balmert M, D'Souza-Schorey C. Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion. Scientific reports 2015; 5:14748; PMID:26458510; http://dx.doi.org/10.1038/srep14748
   PubMed Web of Science ®Google Scholar
• Schlienger S, Campbell S, Claing A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol Biol Cell 2014; 25:17-29; PMID:24196838; http://dx.doi.org/10.1091/mbc.E13-06-0335
   PubMed Web of Science ®Google Scholar
• Charras G, Paluch E. Blebs lead the way: how to migrate without lamellipodia. Nat Rev Mol Cell Biol 2008; 9:730-6; PMID:18628785; http://dx.doi.org/10.1038/nrm2453
   PubMed Web of Science ®Google Scholar
• Pinner S, Sahai E. Imaging amoeboid cancer cell motility in vivo. J Microsc 2008; 231:441-5; PMID:18754999; http://dx.doi.org/10.1111/j.1365-2818.2008.02056.x
   PubMed Web of Science ®Google Scholar
• Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008; 135:510-23; PMID:18984162; http://dx.doi.org/10.1016/j.cell.2008.09.043
   PubMed Web of Science ®Google Scholar
• Liu YJ, Le Berre M, Lautenschlaeger F, Maiuri P, Callan-Jones A, Heuze M, Takaki T, Voituriez R, Piel M. Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells. Cell 2015; 160:659-72; PMID:25679760; http://dx.doi.org/10.1016/j.cell.2015.01.007
   PubMed Web of Science ®Google Scholar
• Ruprecht V, Wieser S, Callan-Jones A, Smutny M, Morita H, Sako K, Barone V, Ritsch-Marte M, Sixt M, Voituriez R, et al. Cortical contractility triggers a stochastic switch to fast amoeboid cell motility. Cell 2015; 160:673-85; PMID:25679761; http://dx.doi.org/10.1016/j.cell.2015.01.008
   PubMed Web of Science ®Google Scholar
• Menju T, Hashimoto S, Hashimoto A, Otsuka Y, Handa H, Ogawa E, Toda Y, Wada H, Date H, Sabe H. Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma. PloS one 2011; 6:e25301; PMID:21966491; http://dx.doi.org/10.1371/journal.pone.0025301
   PubMed Web of Science ®Google Scholar
• Sato H, Hatanaka KC, Hatanaka Y, Hatakeyama H, Hashimoto A, Matsuno Y, Fukuda S, Sabe H. High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients. Cell Commun Signal 2014; 12:17; PMID:24621372; http://dx.doi.org/10.1186/1478-811X-12-17
   PubMed Web of Science ®Google Scholar
• Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada A, Ogawa E, Adachi M, Sakurai T, Manabe T, et al. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J 2005; 24:963-73; PMID:15719014; http://dx.doi.org/10.1038/sj.emboj.7600588
   PubMed Web of Science ®Google Scholar
• Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 2008; 10:85-92; PMID:18084281; http://dx.doi.org/10.1038/ncb1672
   PubMed Web of Science ®Google Scholar
• Sabe H, Hashimoto S, Morishige M, Ogawa E, Hashimoto A, Nam JM, Miura K, Yano H, Onodera Y. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic 2009; 10:982-93; PMID:19416474; http://dx.doi.org/10.1111/j.1600-0854.2009.00917.x
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A, Sabe H. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci USA 2004; 101:6647-52; PMID:15087504; http://dx.doi.org/10.1073/pnas.0401753101
   PubMed Web of Science ®Google Scholar
• Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4:915-25; PMID:14685170; http://dx.doi.org/10.1038/nrm1261
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411:355-65; PMID:11357143; http://dx.doi.org/10.1038/35077225
   PubMed Web of Science ®Google Scholar
• Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005; 5:341-54; PMID:15864276; http://dx.doi.org/10.1038/nrc1609
   PubMed Web of Science ®Google Scholar
• Onodera Y, Nam JM, Hashimoto A, Norman JC, Shirato H, Hashimoto S, Sabe H. Rab5c promotes AMAP1-PRKD2 complex formation to enhance beta1 integrin recycling in EGF-induced cancer invasion. J Cell Biol 2012; 197:983-96; PMID:22734003; http://dx.doi.org/10.1083/jcb.201201065
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Hirose M, Hashimoto A, Morishige M, Yamada A, Hosaka H, Akagi K-i, Ogawa E, Oneyama C, Agatsuma T, et al. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci USA 2006; 103:7036-41; PMID:16636290; http://dx.doi.org/10.1073/pnas.0509166103
   PubMed Web of Science ®Google Scholar
• Hirano M, Hashimoto S, Yonemura S, Sabe H, Aizawa S. EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition. J Cell Biol 2008; 182:1217-30; PMID:18794329; http://dx.doi.org/10.1083/jcb.200712086
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam J-M, Oneyama C, et al. P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance. J Cell Biol 2016; 213(1):81-95; PMID:27044891
   PubMed Web of Science ®Google Scholar
• Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015; 527:472-6; PMID:26560033; http://dx.doi.org/10.1038/nature15748
   PubMed Web of Science ®Google Scholar
• Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015; 527:525-30; PMID:26560028; http://dx.doi.org/10.1038/nature16064
   PubMed Web of Science ®Google Scholar
• Rintoul RC, Sethi T. The role of extracellular matrix in small-cell lung cancer. Lancet Oncol 2001; 2:437-42; PMID:11905738; http://dx.doi.org/10.1016/S1470-2045(00)00421-6
   PubMed Web of Science ®Google Scholar
• Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009; 185:11-9; PMID:19332889; http://dx.doi.org/10.1083/jcb.200807195
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Hashimoto S, Sugino H, Yoshikawa A, Onodera Y, Handa H, Oikawa T, Sabe H. ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance. Oncogenesis 2016; 5:e259; PMID:27617643; http://dx.doi.org/10.1038/oncsis.2016.60
   PubMed Web of Science ®Google Scholar
• Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124:619-26; PMID:8106557; http://dx.doi.org/10.1083/jcb.124.4.619
   PubMed Web of Science ®Google Scholar
• Meredith JE, Jr., Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4:953-61; PMID:8257797; http://dx.doi.org/10.1091/mbc.4.9.953
   PubMed Web of Science ®Google Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002; 295:2387-92; PMID:11923519; http://dx.doi.org/10.1126/science.1067100
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015
   PubMed Web of Science ®Google Scholar